416 The oral HDAC inhibitor SB939 shows activity in in vitro and in vivo models of acute myeloid leukemia
Diermayr, V, Ong, L.C, Loh, Y.K, Cheong, A, Hart, S, Goh, K.C, Hentze, H.H, Wang, H, Ethirajulu, K.E, Wood, J.M
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
83 POSTER A robust and quantitative biomarker assay for SB939, a potent, orally-active HDAC inhibitor
Novotny-Diermayr, V, Nayagam, V.M, Hentze, H.H, Liang, A.L, Loh, Y.K, Sausgruber, N, Yeo, P, Ethirajulu, K, Wood, J.M
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article